AACR19: pembrolizumab demonstrates promise in small-cell lung cancer patients

Keytruda┬« (pembrolizumab) has demonstrated promising anti-tumor activity in patients with pretreated, advanced-small cell lung cancer (SCLC) according to pooled analysis … Continue reading AACR19: pembrolizumab demonstrates promise in small-cell lung cancer patients